Clinical usefulness of oral immunoglobulins in lung transplant recipients with norovirus gastroenteritis: A case series

Transplantation Proceedings

Volumn 46, Issue 10, 2014, Pages 3603-3605

  Gairard Dory, A C ^a   Degot T ^a   Hirschi, S ^a   Schuller, A ^a   Leclercq, A ^a   Renaud Picard, B ^a   Gourieux, B ^a   Kessler, R ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; IMMUNOLOGIC FACTOR;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; LUNG TRANSPLANTATION; MALE; NOROVIRUS; NOROVIRUS GASTROENTERITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; VIRAL GASTROENTERITIS; CALICIVIRIDAE INFECTIONS; GASTROENTERITIS; GRAFT RECIPIENT; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VIROLOGY;

ADMINISTRATION, ORAL; CALICIVIRIDAE INFECTIONS; FEMALE; GASTROENTERITIS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NOROVIRUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TRANSPLANT RECIPIENTS;

EID: 84926366706     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.09.095     Document Type: Article

References (21)

1. Bravo C, Gispert P, Borro JM, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc 2007;39:2409-12.
2. Jokinen JJ, Hämmäinen P, Lemström KB, et al. Association between gastrointestinal symptoms and health-related quality of life after heart transplantation. J Heart Lung Transplant 2010;29: 1388-94.
3. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002;13: 277-87.
4. Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008;51:478-9.
5. Vanhove T, Kuypers D, Claes KJ, et al. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome. Transpl Int 2013;26:813-21.
6. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012;367:2126-32.
7. Stelzmueller I, Wiesmayr S, Swenson BR, et al. Rotavirus enteritis in solid organ transplant recipients: An underestimated problem? Transpl Infect Dis 2007;9:281-5.
8. Stelzmueller I, Dunst KM, Hengster P, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int 2005;18:470-4.
9. Schorn R, Höhne M, Meerbach A, et al. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clin Infect Dis 2010;51:307-14.
10. Adeyi OA, Costa G, Abut-Elmagd KM, Wu T. Rotavirus infection in adults small intestine allografts: A clinicopathological study of a cohort of 23 patients. Am J Transplant 2010;10:2683-9.
11. Kaufman SS, Chatterjee NK, Fuschino ME, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 2003;3:764-8.
12. Florescu DF,McCartanMA, GrantW. Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant 2008;12:372-5.
13. Liakopoulou E, Mutton K, Carrington D, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogenic bone marrow transplantation. Bone Marrow Transplant 2005;36:691-4.
14. Robles JD, Cheuk DK, SY H, et al. Norovirus infection in pediatric hematopioetic stem cell transplantation recipients: Incidence, risk factors and outcome. Biol Blood Marrow Transplant 2012;18:1883-9.
15. Roos-Weil D, Ambert-Balay K, Lanternier F. Impact of Norovirus/Sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 2011;92:61-9.
16. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: Etiology and management. Liver Transpl 2005;11: 881-890.
17. Losonsky G, Johnson JP, Winkelstein JA, et al. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. J Clin Invest 1985;76: 2362-7.
18. Kanfer EJ, Abrahamson G, Taylor J, et al. Severe rotavirusassociated diarrhoea following bone marrow transplantation: Treatment with oral immunoglobulin. Bone Marrow Transplant 1994;14:651-2.
19. Chagla Z, Quirt J, Woodward K, Neary J, Rutherford C. Chronic norovirus infection in a transplant patient successfully treated with enterally administrered immune globulin. J Clin Virol 2013;58:306-8.
20. Boillat Blanco N, Kuonen R, Bellini C, et al. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis 2011;13:213-5.
21. Atmar RL, Bernstein DI, Harro CE, et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011;365:2178-87.